Pessa M E, Howard R J
Surg Gynecol Obstet. 1985 Sep;161(3):257-60.
Although Hickman-Broviac catheters have improved the care of patients with leukemia and patients using catheters for hyperalimentation, they are associated with a substantial morbidity. We experienced a 34 per cent complication rate. Some of these complications may be relieved with new therapy (streptokinase) and some of the intraoperative problems can be prevented by a more careful technique. We believe the cephalic vein cutdown technique remains the procedure of choice. Due to the morbidity of placement, every attempt should be made to save a catheter, as in type 1 infections. Type 2 infections should be the major indication for removal of the catheters.
尽管希克曼-布罗维亚克导管改善了白血病患者以及使用导管进行胃肠外营养患者的护理，但它们会引发相当高的发病率。我们经历了34%的并发症发生率。其中一些并发症可用新疗法（链激酶）缓解，一些术中问题可通过更精细的技术预防。我们认为头静脉切开技术仍是首选方法。鉴于置管引发的发病率，应尽一切努力保留导管，如1型感染时那样。2型感染应是拔除导管的主要指征。
